Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8+ T cells
Jesús Corría-Osorio(Ludwig Cancer Research), George Coukos(University Hospital of Lausanne)
Cited by 46
Related Papers
Deciphering and Reversing Tumor Immune Suppression
|Immunity|2013|597
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
|Frontiers in Immunology|2019|423
Targeting the tumor vasculature to enhance T cell activity
|Current Opinion in Immunology|2015|330
Whole tumor antigen vaccines
|Seminars in Immunology|2010|243